©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 109830
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.109830
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.109830
Figure 1 Pancreatic cancer tumor microenvironment and multidimensional therapeutic strategy.
AG: Gemcitabine plus nab-paclitaxel; Treg: Regulatory T cell; PEGPH20: Pegylated recombinant human hyaluronidase PH20; PD-1: Programmed cell death protein 1; myCAF: Myofibroblastic cancer-associated fibroblast; PDAC: Pancreatic ductal adenocarcinoma.
- Citation: Zhao K, Xiao MM, Yang YS, Xiao X. Tumor microenvironment phenotyping guides precision therapy in unresectable pancreatic cancer. World J Gastrointest Oncol 2025; 17(10): 109830
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/109830.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.109830